<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id><journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id><journal-id journal-id-type="publisher-id">bioinformatics</journal-id><journal-title-group><journal-title>Bioinformatics</journal-title></journal-title-group><issn pub-type="ppub">1367-4803</issn><issn pub-type="epub">1367-4811</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6735703</article-id><article-id pub-id-type="doi">10.1093/bioinformatics/btz018</article-id><article-id pub-id-type="publisher-id">btz018</article-id><article-categories><subj-group subj-group-type="heading"><subject>Applications Notes</subject><subj-group subj-group-type="category-toc-heading"><subject>Sequence Analysis</subject></subj-group></subj-group></article-categories><title-group><article-title>SMuRF: portable and accurate ensemble prediction of somatic mutations</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Weitai</given-names></name><xref ref-type="aff" rid="btz018-aff1">1</xref><xref ref-type="aff" rid="btz018-aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yu Amanda</given-names></name><xref ref-type="aff" rid="btz018-aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Muthukumar</surname><given-names>Karthik</given-names></name><xref ref-type="aff" rid="btz018-aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Baruah</surname><given-names>Probhonjon</given-names></name><xref ref-type="aff" rid="btz018-aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Mei Mei</given-names></name><xref ref-type="aff" rid="btz018-aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jacobsen Skanderup</surname><given-names>Anders</given-names></name><xref ref-type="aff" rid="btz018-aff1">1</xref><xref ref-type="corresp" rid="btz018-cor1"/><!--<email>skanderupamj@gis.a-star.edu.sg</email>--></contrib></contrib-group><aff id="btz018-aff1"><label>1</label>Department of Computational and Systems Biology, <institution>Agency for Science Technology and Research, Genome Institute of Singapore</institution>, Singapore, Singapore</aff><aff id="btz018-aff2"><label>2</label>
<institution>Graduate School of Integrative Sciences and Engineering, National University of Singapore</institution>, Singapore, Singapore</aff><contrib-group><contrib contrib-type="editor"><name><surname>Birol</surname><given-names>Inanc</given-names></name><role>Associate Editor</role></contrib></contrib-group><author-notes><corresp id="btz018-cor1">To whom correspondence should be addressed. E-mail: <email>skanderupamj@gis.a-star.edu.sg</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="epub" iso-8601-date="2019-01-12"><day>12</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>1</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>35</volume><issue>17</issue><fpage>3157</fpage><lpage>3159</lpage><history><date date-type="received"><day>1</day><month>8</month><year>2018</year></date><date date-type="rev-recd"><day>26</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>7</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019. Published by Oxford University Press.</copyright-statement><copyright-year>2019</copyright-year><license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="btz018.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Summary</title><p>Somatic Mutation calling method using a Random Forest (SMuRF) integrates predictions and auxiliary features from multiple somatic mutation callers using a supervised machine learning approach. SMuRF is trained on community-curated matched tumor and normal whole genome sequencing data. SMuRF predicts both SNVs and indels with high accuracy in genome or exome-level sequencing data. Furthermore, the method is robust across multiple tested cancer types and predicts low allele frequency variants with high accuracy. In contrast to existing ensemble-based somatic mutation calling approaches, SMuRF works out-of-the-box and is orders of magnitudes faster.</p></sec><sec id="s2"><title>Availability and implementation</title><p>The method is implemented in R and available at <ext-link ext-link-type="uri" xlink:href="https://github.com/skandlab/SMuRF">https://github.com/skandlab/SMuRF</ext-link>. SMuRF operates as an add-on to the community-developed bcbio-nextgen somatic variant calling pipeline.</p></sec><sec id="s3"><title>Supplementary information</title><p>
<xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p></sec></abstract><funding-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">Open Fund Individual Research</named-content></funding-source></award-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">Singapore National Medical Research Council</named-content></funding-source><award-id>OFIRG15nov072</award-id></award-group></funding-group><counts><page-count count="3"/></counts></article-meta></front><body><sec sec-type="intro"><title>1 Introduction</title><p>Identification of somatic mutations from matched tumor and normal samples is challenged by sequencing noise and alignment ambiguities as well as the heterogeneous composition of tumors. Recent studies have revealed low concordance between existing methods for somatic variant calling (<xref rid="btz018-B8" ref-type="bibr">Hwang <italic>et&#x000a0;al.</italic>, 2015</xref>; <xref rid="btz018-B10" ref-type="bibr">Kroigard <italic>et&#x000a0;al.</italic>, 2016</xref>; <xref rid="btz018-B12" ref-type="bibr">O&#x02019;Rawe <italic>et&#x000a0;al.</italic>, 2013</xref>; <xref rid="btz018-B14" ref-type="bibr">Roberts <italic>et&#x000a0;al.</italic>, 2013</xref>). Additionally, a benchmark study demonstrated that the accuracy of a given somatic mutation calling algorithm can vary extensively across different workflows and pipelines (<xref rid="btz018-B1" ref-type="bibr">Alioto <italic>et&#x000a0;al.</italic>, 2015</xref>). Parameters influencing this variation may be choice of alignment algorithm, use of local re-alignment, as well as configuration of a multitude of post-processing filters. The consensus of multiple callers have been used to improve the accuracy of somatic variant calling (<xref rid="btz018-B2" ref-type="bibr">Callari <italic>et&#x000a0;al.</italic>, 2017</xref>; <xref rid="btz018-B5" ref-type="bibr">Ellrott <italic>et&#x000a0;al.</italic>, 2018</xref>; <xref rid="btz018-B13" ref-type="bibr">Rashid <italic>et&#x000a0;al.</italic>, 2013</xref>). Taking this one step further, a machine learning based ensemble method may combine multiple mutation callers with auxiliary sequence and alignment features to improve mutation calling accuracy (<xref rid="btz018-B4" ref-type="bibr">Ding <italic>et&#x000a0;al.</italic>, 2012</xref>; <xref rid="btz018-B7" ref-type="bibr">Fang <italic>et&#x000a0;al.</italic>, 2015</xref>; <xref rid="btz018-B16" ref-type="bibr">Wood <italic>et&#x000a0;al.</italic>, 2018</xref>). While such approaches may improve accuracy, they are generally not portable: The end-user must obtain suitable training and testing datasets and need to have knowledge of machine learning (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S1A</xref> ). There is therefore a need for accurate and pre-trained ensemble approaches for somatic mutation calling that can be ported between research groups. Here, we developed a Somatic Mutation calling method using a Random Forest (SMuRF), which combines predictions from four mutation callers with auxiliary alignment and mutation features using supervised machine learning (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S1B</xref>).</p></sec><sec><title>2 Implementation</title><p>SMuRF is available as an R package. Briefly, the bcbio-nextgen framework (<ext-link ext-link-type="uri" xlink:href="https://github.com/chapmanb/bcbio-nextgen">https://github.com/chapmanb/bcbio-nextgen</ext-link>) is used to generate somatic variant calls from 4 different methods: MuTect2 (<xref rid="btz018-B3" ref-type="bibr">Cibulskis <italic>et&#x000a0;al.</italic>, 2013</xref>), Freebayes somatic (ArXiv: <ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1207.3907">https://arxiv.org/abs/1207.3907</ext-link>), VarDict (<xref rid="btz018-B11" ref-type="bibr">Lai <italic>et&#x000a0;al.</italic>, 2016</xref>) and VarScan (<xref rid="btz018-B9" ref-type="bibr">Koboldt <italic>et&#x000a0;al.</italic>, 2012</xref>). Variant and auxiliary features are extracted from the VCF files. The SMuRF random forest model is pre-trained on a gold standard set of mutation calls curated by the International Cancer Genome Consortium (ICGC) community using deep (&#x0003e;100&#x000d7;) whole genome sequencing (WGS) of two tumors (<xref rid="btz018-B1" ref-type="bibr">Alioto <italic>et&#x000a0;al.</italic>, 2015</xref>). Feature extraction and prediction of somatic variants takes &#x0223c;10&#x02009;min for tumor-normal WGS data on a standard computer (4 CPUs, 16GB RAM).</p></sec><sec sec-type="intro"><title>3 Overview</title><p>SMuRF SNV and indel models were trained on matched tumor-normal WGS data from a chronic lymphocytic leukemia (CLL) patient and a medulloblastoma (MB) patient, where the true somatic mutations have been identified and curated by the International Cancer Genome Consortium (ICGC) (<xref rid="btz018-B1" ref-type="bibr">Alioto <italic>et&#x000a0;al.</italic>, 2015</xref>). The training data was augmented to expose the model to additional variation in sequencing coverage, tumor purity and tumor/normal coverage imbalance (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S1C</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Methods</xref>). SMuRF was trained on 80% of the data, with 20% of the data withheld as a test set. Highly predictive features were mostly somatic variant scores provided by individual methods as well as mapping and base quality estimates (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>). SMuRF achieved F1-scores of 0.88 and 0.74 for SNVs and indels, respectively (<xref ref-type="fig" rid="btz018-F1">Fig. 1</xref>A and B, <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S2</xref> and <xref ref-type="supplementary-material" rid="sup1">S3</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S3</xref> for SNV coding regions). Importantly, SMuRF showed improved accuracy over the best mutation calling submissions reported in the benchmark by Alioto et&#x000a0;al. using the same dataset (best reported F1-scores 0.79 and 0.65 for SNV and indels, respectively) (<xref rid="btz018-B1" ref-type="bibr">Alioto <italic>et&#x000a0;al.</italic>, 2015</xref>). In our analysis, while individual methods could recover most of the true SNVs, this came at the cost of very low precision (&#x0003c;40% precision at 80% recall) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S2</xref>). In contrast, SMuRF could recover 86% of the true SNVs (recall) at 92% precision on the withheld test set. While a simple consensus approach using the intersection of individual methods performed well (F1&#x02009;=&#x02009;0.82), SMuRF achieved markedly higher recall (86% versus 74%) at a similar level of precision. All methods, including SMuRF, were mostly robust when tested under different levels of tumor purity (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S4</xref>). However, SMuRF showed substantially improved accuracy at low somatic variant allele frequencies (VAFs) as compared to individual methods (<xref ref-type="fig" rid="btz018-F1">Fig. 1</xref>C), which is particularly important in the setting of tumor heterogeneity inference (<xref rid="btz018-B15" ref-type="bibr">Shi <italic>et&#x000a0;al.</italic>, 2018</xref>). We further benchmarked SMuRF SNV calling using independent data from the DREAM Somatic Mutation Challenge where artificial tumor data has been generated using an in-silico approach (<xref rid="btz018-B6" ref-type="bibr">Ewing <italic>et&#x000a0;al.</italic>, 2015</xref>). While the performance of individual methods varied across these datasets, SMuRF was highly accurate across all synthetic tumors (F1&#x02009;&#x0003e;&#x02009;0.8) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S5</xref>). Overall, these results support that SMuRF is robust and can generalize to unseen data.</p><fig id="btz018-F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Performance of SMuRF. Precision-recall profiles for individual somatic mutation callers and SMuRF evaluated on (<bold>A</bold>) SNV and (<bold>B</bold>) indels using 20% withheld test data. Curves show the performance of the individual algorithms under different variant score thresholds (MuTect2 tumor log-odds score, Freebayes log-odds score, VarDict SSF score, VarScan SSC score and SMuRF confidence score). Solid points refer to the default performance of the caller in the bcbio-nextgen workflow. Black solid points denote the accuracy of calls identified by the majority-voting scheme in bcbio-nextgen (at least 1, 2, 3 or 4 callers). The grey contours indicate F1 scores as a function of recall and precision. (<bold>C</bold>) Accuracy of SMuRF and individual callers as a function of somatic variant allele frequency in the test set; F1 scores evaluated for each variant allele frequency bin. (<bold>D&#x02013;F</bold>) Evaluation of SMuRF and SomaticSeq performance when trained and tested across different cancer types. (D) Models were trained on 70% of CLL data and tested on 30% of MB data (and vice versa). F1 scores were recorded for SMuRF and SomaticSeq SNV (E) and indel (F) predictions. Error bars represent the standard deviation of the mean across 10 random training/test data splits (same splits for both methods)</p></caption><graphic xlink:href="btz018f1"/></fig><p>Analysis of indel prediction accuracy showed that individual mutation callers could recover most of the true indels (64&#x02013;94% recall), but only at the cost of very low precision (&#x0003c;8%). Interestingly, simple consensus approaches performed well for indel prediction (F1 0.46 and 0.66 for 3 and 4-caller consensus, respectively). However, while consensus methods suffered from either low recall (0.55) or precision (0.31), SMuRF obtained high indel prediction accuracy (F1&#x02009;=&#x02009;0.74) with both high recall (0.74) and precision (0.75) (<xref ref-type="fig" rid="btz018-F1">Fig. 1</xref>B, <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). We also analyzed the extent that SMuRF predicts the same somatic mutations in tumor samples profiled with both (&#x0003e;200&#x000d7; coverage) WES and (&#x0003c;100&#x000d7; coverage) WGS. When restricting analysis to variants in coding regions, SMuRF predicted somatic SNVs and indels with comparable or higher concordance than individual methods (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figs S6</xref> and <xref ref-type="supplementary-material" rid="sup1">S7</xref>).</p><p>Finally, we compared SMuRF to two existing machine learning-based methods. The first was MutationSeq, a pre-trained ensemble SNV caller (<xref rid="btz018-B4" ref-type="bibr">Ding <italic>et&#x000a0;al.</italic>, 2012</xref>), which achieved an F1-score of 0.68, similar to the other individual SNV callers in our analysis (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S8</xref>). Next, we compared the performance of SomaticSeq (<xref rid="btz018-B7" ref-type="bibr">Fang <italic>et&#x000a0;al.</italic>, 2015</xref>), a method that required users to train their own predictive model (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Methods</xref>). The trained SomaticSeq model had slightly increased test set prediction accuracy over SMuRF for both SNV (0.90 versus 0.88) and indels (0.78 versus 0.75) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S9B and C</xref>). We further evaluated how the methods generalized when models were trained and tested across different tumor datasets and found that SomaticSeq showed greater test accuracy variation (<xref ref-type="fig" rid="btz018-F1">Fig. 1</xref>D&#x02013;F). This was especially pronounced for indel prediction, where the F1 accuracy of SomaticSeq varied from 0.48 to 0.73 (SMuRF 0.63&#x02013;0.65) when tested on the MBL or CLL sample, respectively. Furthermore, SomaticSeq used &#x0223c;24&#x02009;h to predict both SNVs and indels since it also computes auxiliary features from the raw alignment data. In contrast, SMuRF depends only on VCF files and predicts both SNVs and indels in &#x0223c;10&#x02009;min (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S9A</xref>). Overall, these results support that SMuRF is both accurate and computationally efficient.</p><p>In summary, SMuRF is an accurate, portable and user-friendly ensemble-based somatic mutation caller, which should benefit both cancer genomics studies as well as clinical applications.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sup1"><label>btz018_Supplementary_Materials</label><media xlink:href="btz018_supplementary_materials.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="ack1"><title>Acknowledgements</title><p>We thank I. Kassam, N. Rohatgi, K. Krishnamachari, M. N. Mojtabavi, G. Zhu, U. Ghoshdastider and T. Kulshrestha for their support and discussion during the development and testing of SMuRF.</p></ack><sec><title>Funding</title><p>This work was supported by an Open Fund Individual Research Grant from the Singapore National Medical Research Council (OFIRG15nov072).</p><p>
<italic>Conflict of Interest</italic>: none declared.</p></sec><ref-list id="ref1"><title>References</title><ref id="btz018-B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alioto</surname><given-names>T.S.</given-names></name><etal>et al</etal></person-group> (<year>2015</year>) 
<article-title>A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing</article-title>. <source>Nat. Commun.</source>, <volume>6</volume>, <fpage>10001</fpage>.<pub-id pub-id-type="pmid">26647970</pub-id></mixed-citation></ref><ref id="btz018-B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Callari</surname><given-names>M.</given-names></name><etal>et al</etal></person-group> (<year>2017</year>) 
<article-title>Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers</article-title>. <source>Genome Med.</source>, <volume>9</volume>, <fpage>35</fpage>.<pub-id pub-id-type="pmid">28420412</pub-id></mixed-citation></ref><ref id="btz018-B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cibulskis</surname><given-names>K.</given-names></name><etal>et al</etal></person-group> (<year>2013</year>) 
<article-title>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</article-title>. <source>Nat. Biotechnol.</source><italic>,</italic><volume>31</volume>, <fpage>213</fpage>.<pub-id pub-id-type="pmid">23396013</pub-id></mixed-citation></ref><ref id="btz018-B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name><etal>et al</etal></person-group> (<year>2012</year>) 
<article-title>Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data</article-title>. <source>Bioinformatics (Oxford, England)</source>, <volume>28</volume>, <fpage>167</fpage>&#x02013;<lpage>175</lpage>.</mixed-citation></ref><ref id="btz018-B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ellrott</surname><given-names>K.</given-names></name><etal>et al</etal></person-group> (<year>2018</year>) 
<article-title>Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines</article-title>. <source>Cell Syst.</source>, <volume>6</volume>, <fpage>271</fpage>&#x02013;<lpage>281.e277</lpage>.<pub-id pub-id-type="pmid">29596782</pub-id></mixed-citation></ref><ref id="btz018-B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ewing</surname><given-names>A.D.</given-names></name><etal>et al</etal></person-group> (<year>2015</year>) 
<article-title>Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection</article-title>. <source>Nat. Methods</source>, <volume>12</volume>, <fpage>623</fpage>.<pub-id pub-id-type="pmid">25984700</pub-id></mixed-citation></ref><ref id="btz018-B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>L.T.</given-names></name><etal>et al</etal></person-group> (<year>2015</year>) 
<article-title>An ensemble approach to accurately detect somatic mutations using SomaticSeq</article-title>. <source>Genome Biol.</source><italic>,</italic><volume>16</volume>, <fpage>197</fpage>.<pub-id pub-id-type="pmid">26381235</pub-id></mixed-citation></ref><ref id="btz018-B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>S.</given-names></name><etal>et al</etal></person-group> (<year>2015</year>) 
<article-title>Systematic comparison of variant calling pipelines using gold standard personal exome variants</article-title>. <source>Sci. Rep.</source><volume>5</volume>, <fpage>17875</fpage>.<pub-id pub-id-type="pmid">26639839</pub-id></mixed-citation></ref><ref id="btz018-B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koboldt</surname><given-names>D.C.</given-names></name><etal>et al</etal></person-group> (<year>2012</year>) 
<article-title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article-title>. <source>Genome Res.</source>, <volume>22</volume>, <fpage>568</fpage>&#x02013;<lpage>576</lpage>.<pub-id pub-id-type="pmid">22300766</pub-id></mixed-citation></ref><ref id="btz018-B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kroigard</surname><given-names>A.B.</given-names></name><etal>et al</etal></person-group> (<year>2016</year>) 
<article-title>Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data</article-title>. <source>PLoS One</source><italic>,</italic><volume>11</volume>, <fpage>e0151664</fpage>.<pub-id pub-id-type="pmid">27002637</pub-id></mixed-citation></ref><ref id="btz018-B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>Z.</given-names></name><etal>et al</etal></person-group> (<year>2016</year>) 
<article-title>VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research</article-title>. <source>Nucleic Acids Res.</source><italic>,</italic><volume>44</volume>, <fpage>e108</fpage>.<pub-id pub-id-type="pmid">27060149</pub-id></mixed-citation></ref><ref id="btz018-B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>O&#x02019;Rawe</surname><given-names>J.</given-names></name><etal>et al</etal></person-group> (<year>2013</year>) 
<article-title>Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing</article-title>. <source>Genome Med.</source>, <volume>5</volume>, <fpage>28</fpage>.<pub-id pub-id-type="pmid">23537139</pub-id></mixed-citation></ref><ref id="btz018-B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>M.</given-names></name><etal>et al</etal></person-group> (<year>2013</year>) 
<article-title>Cake: a bioinformatics pipeline for the integrated analysis of somatic variants in cancer genomes</article-title>. <source>Bioinformatics (Oxford, England)</source>, <volume>29</volume>, <fpage>2208</fpage>&#x02013;<lpage>2210</lpage>.</mixed-citation></ref><ref id="btz018-B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>N.D.</given-names></name><etal>et al</etal></person-group> (<year>2013</year>) 
<article-title>A comparative analysis of algorithms for somatic SNV detection in cancer</article-title>. <source>Bioinformatics (Oxford, England)</source><italic>,</italic><volume>29</volume>, <fpage>2223</fpage>&#x02013;<lpage>2230</lpage>.</mixed-citation></ref><ref id="btz018-B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name><etal>et al</etal></person-group> (<year>2018</year>) 
<article-title>Reliability of whole-exome sequencing for assessing intratumor genetic heterogeneity</article-title>. <source>Cell Rep.</source><italic>,</italic><volume>25</volume>, <fpage>1446</fpage>&#x02013;<lpage>1457</lpage>.<pub-id pub-id-type="pmid">30404001</pub-id></mixed-citation></ref><ref id="btz018-B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wood</surname><given-names>D.E.</given-names></name><etal>et al</etal></person-group> (<year>2018</year>) 
<article-title>A machine learning approach for somatic mutation discovery</article-title>. <source>Sci. Transl. Med.</source>, <volume>10</volume>, <fpage>eaar7939</fpage>.<pub-id pub-id-type="pmid">30185652</pub-id></mixed-citation></ref></ref-list></back></article>